FWM
Frontier Wealth Management Portfolio holdings
AUM
$1.38B
This Quarter Return
+3%
1 Year Return
+6.29%
3 Year Return
+42.9%
5 Year Return
+78.39%
10 Year Return
–
AUM
$650M
AUM Growth
+$650M
(+4.4%)
Cap. Flow
+$21.7M
Cap. Flow
% of AUM
3.34%
Top 10 Holdings %
Top 10 Hldgs %
33.36%
Holding
398
New
90
Increased
138
Reduced
95
Closed
54
Top Buys
| 1 |
Gilead Sciences
GILD
|
$9.02M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
$8.42M |
| 3 |
Schwab Short-Term US Treasury ETF
SCHO
|
$7.41M |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$6.45M |
| 5 |
Schwab US TIPS ETF
SCHP
|
$5.71M |
Top Sells
| 1 |
General Mills
GIS
|
$66.3M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
$13.1M |
| 3 |
SPDR S&P MidCap 400 ETF Trust
MDY
|
$9.19M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
$8.15M |
| 5 |
Invesco Fundamental High Yield Corporate Bond ETF
PHB
|
$4.89M |
Sector Composition
| 1 | Energy | 18% |
| 2 | Healthcare | 10.47% |
| 3 | Technology | 5.62% |
| 4 | Consumer Staples | 4.06% |
| 5 | Consumer Discretionary | 3.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
GeoPark
GPRK
$340M
| $90.4M | 13.91% | 19,151,726 +69,479 | +0.4% | +$328K |
|
2
Invesco FTSE RAFI US 1000 ETF
PRF
$8.08B
| $20.5M | 3.15% | 225,946 -6,667 | -3% | -$605K |
|
3
iShares MBS ETF
MBB
$41B
| $16.6M | 2.55% | 152,643 -5,438 | -3% | -$591K |
|
4
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.54B
| $16M | 2.47% | 154,468 +2,032 | +1% | +$211K |
|
5
Schwab International Equity ETF
SCHF
$50.3B
| $15.8M | 2.43% | 518,855 -2,033 | -0.4% | -$61.9K |
|
|
6
Schwab Short-Term US Treasury ETF
SCHO
$11.7B
| $14.3M | 2.19% | 281,051 +146,130 | +108% | +$7.41M |
|
7
Procter & Gamble
PG
$368B
| $11.6M | 1.78% | 147,622 +8,917 | +6% | +$698K |
|
8
Apple
AAPL
$3.45T
| $10.9M | 1.68% | 87,240 +39,935 | +84% | +$5.01M |
|
|
9
Schwab US TIPS ETF
SCHP
$13.9B
| $10.5M | 1.61% | 192,911 +105,349 | +120% | +$5.71M |
|
10
Schwab Intermediately-Term US Treasury ETF
SCHR
$11.5B
| $10.3M | 1.59% | 193,021 +92,452 | +92% | +$4.96M |
|
|
11
Gilead Sciences
GILD
$140B
| $9.58M | 1.47% | 81,845 +77,053 | +1,608% | +$9.02M |
|
12
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.11B
| $8.98M | 1.38% | 220,617 +5,550 | +3% | +$226K |
|
13
Vanguard Short-Term Bond ETF
BSV
$38.5B
| $8.82M | 1.36% | 110,014 -2,743 | -2% | -$220K |
|
14
Vanguard Intermediate-Term Bond ETF
BIV
$24.1B
| $8.58M | 1.32% | 102,316 -2,200 | -2% | -$185K |
|
|
15
Berkshire Hathaway Class A
BRK.A
$1.09T
| $8.42M | 1.3% | 57,438 +57,434 | +1,435,850% | +$8.42M |
|
16
iShares 20+ Year Treasury Bond ETF
TLT
$47.8B
| $7.86M | 1.21% | 66,893 +34,584 | +107% | +$4.06M |
|
17
Vanguard Real Estate ETF
VNQ
$34.6B
| $6.76M | 1.04% | 90,563 -798 | -0.9% | -$59.6K |
|
18
Schwab Emerging Markets Equity ETF
SCHE
$10.7B
| $6.58M | 1.01% | 267,803 -2,048 | -0.8% | -$50.3K |
|
|
CLVS
19
DELISTED
Clovis Oncology, Inc.
CLVS
| $6.45M | 0.99% | +73,345 | New | +$6.45M |
|
20
Amgen
AMGN
$155B
| $6.38M | 0.98% | 41,573 +35,973 | +642% | +$5.52M |
|
21
Invesco FTSE RAFI Developed Markets ex-US Small-Mid ETF
PDN
$359M
| $6.32M | 0.97% | 224,679 +6,793 | +3% | +$191K |
|
22
Vanguard Long-Term Bond ETF
BLV
$5.53B
| $6.24M | 0.96% | 71,268 -815 | -1% | -$71.4K |
|
23
iShares Russell Mid-Cap Value ETF
IWS
$14.1B
| $5.63M | 0.87% | 76,345 -3,742 | -5% | -$276K |
|
|
CELG
24
DELISTED
Celgene Corp
CELG
| $5.27M | 0.81% | 45,571 +43,042 | +1,702% | +$4.98M |
|
25
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$13.4B
| $5.2M | 0.8% | 47,279 -5,872 | -11% | -$645K |
|